サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566898

体外式膜酸素化装置市場：タイプ別、コンポーネント別、用途別：世界の機会分析と産業予測、2024年～2033年

Extracorporeal Membrane Oxygenation Machine Market By Type , By Components By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
体外式膜酸素化装置市場：タイプ別、コンポーネント別、用途別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外膜酸素化装置（ECMO）市場は、2023年に5億420万米ドルと評価され、2024年から2033年までのCAGRは4.6％で成長し、2033年には7億9,370万米ドルに達すると予測されています。

体外膜酸素化装置（ECMO）は、二酸化炭素の除去を補助し、酸素を豊富に含む血液を体内に戻す医療機器です。この機械は、心機能障害や肺機能障害を患う患者を治療するための生命維持装置としての役割を果たします。ECMOは、血液を人工肺（膜型酸素供給装置）を通して血流に戻し、循環させることで機能します。このプロセスにより、血液は酸素化され二酸化炭素が除去され、人間の肺と心臓の機能を効果的に模倣することができます。

体外式膜酸素供給装置（ECMO）市場の世界の成長は、心不全や心原性ショックなどの呼吸器疾患や心疾患の憂慮すべき有病率の上昇が主な要因となっています。英国国家統計局の推計によると、約660万人が心血管疾患または呼吸器疾患のいずれかに罹患しています。そのうち350万人が心血管系疾患、370万人が呼吸器系疾患と報告されています。さらに、医療従事者の意識の向上と医療トレーニングの進歩が、ECMOの普及につながっています。体外生命維持装置（ELSO）レジストリの2023年6月の評価によると、ECMOは2020年に151,683人の患者に使用されました。このうち、75,735人が成人、30,743人が小児、45,205人が新生児でした。さらに、老人人口の急増も市場成長に大きく寄与しています。.これは、高齢者は機能障害により慢性疾患や臓器不全にかかりやすく、日常生活の遂行能力が制限されるため、ECMOの需要を押し上げているという事実に起因しています。世界保健機関（WHO）によると、60歳以上の高齢者数は2019年に10億人だった。この数は2030年には14億人、2050年には21億人に増加すると推定されており、市場成長に大きく寄与する可能性が高いです。しかし、ECMOシステムの初期投資とメンテナンスコスト、システムを操作する熟練者の不足が市場成長の妨げとなっています。さらに、多くの国では人口のニーズを満たす適切な医療施設がなく、アクセスが限られていることも市場の主要な阻害要因となっています。これとは反対に、より小型で効率的なシステムを含むECMO技術の継続的な改善や、重症患者用医療インフラの設置・開発に対する政府の資金援助や支援の増加は、予測期間中の市場拡大に有利な機会を提供すると期待されています。

体外式膜酸素吸入装置（ECMO）市場は、タイプ、コンポーネント、用途、地域に区分されます。タイプによって、市場は静脈-動脈、静脈-静脈、動脈-静脈に分類されます。コンポーネント別では、ポンプ、酸素供給器、コントローラー、その他に分類されます。用途別では、成人、小児、新生児に分類されます。地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

タイプ別では、2033年までに動脈-静脈装置セグメントが市場を独占すると予測されます。

コンポーネント別では、酸素供給器が予測期間中に主要セグメントとして浮上すると予測されています。

用途別では、成人用セグメントが今後数年間で顕著なCAGRを示すと予測されています。

地域別では、北米が2023年の主要収益貢献国であり、予測期間中に市場を独占する可能性が高いです。

本レポートのカスタマイズの可能性（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 体外式膜酸素化装置（ECMO）市場：タイプ別

  • 市場概要
  • 静脈動脈
  • 静脈
  • その他

第5章 体外式酸素供給装置（ECMO）市場：コンポーネント別

  • 市場概要
  • ポンプ
  • 酸素供給器
  • コントローラー
  • その他

第6章 体外式酸素供給装置（ECMO）市場：用途別

  • 市場概要
  • 成人
  • 小児
  • 新生児

第7章 体外式膜酸素化装置（ECMO）市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の体外式膜酸素化装置（ECMO）市場
    • カナダの体外式膜酸素化装置（ECMO）市場
    • 体外式膜酸素化装置（ECMO）のメキシコ市場
  • 欧州
    • 主な市場動向と機会
    • フランスの体外式膜酸素化装置（ECMO）市場
    • ドイツの体外式膜酸素化装置（ECMO）市場
    • イタリアの体外式膜酸素化装置（ECMO）市場
    • スペインの体外式膜酸素化装置（ECMO）市場
    • 英国の体外式膜酸素化装置（ECMO）市場
    • その他欧州の体外式膜酸素化装置（ECMO）市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の体外式膜酸素化装置（ECMO）市場
    • 日本の体外式膜酸素化装置（ECMO）市場
    • 体外式膜酸素化装置（ECMO）のインド市場
    • 韓国の体外式膜酸素化装置（ECMO）市場
    • オーストラリア体外式膜酸素化装置（ECMO）市場
    • その他アジア太平洋の体外式膜酸素化装置（ECMO）市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • 体外式膜酸素化装置（ECMO）のブラジル市場
    • 南アフリカの体外式膜酸素化装置（ECMO）市場
    • サウジアラビアの体外式膜酸素化装置（ECMO）市場
    • その他のラテンアメリカ・中東・アフリカの体外式膜酸素化装置（ECMO）市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Medtronic Plc
  • Sorin Group
  • Terumo Corporation
  • MAQUET Holding
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Medos Medizintechnik AG
  • GETINGE AB
  • Livanova Plc
  • Fresnius Medical Care
目次
Product Code: A284556

The extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.

Extracorporeal membrane oxygenation machine (ECMO) is a medical device that assists in removal of carbon dioxide and sends oxygen-rich blood back to the body. The machine serves as a life support system to treat individuals suffering from cardiac and pulmonary dysfunction. ECMO functions by circulating blood through an artificial lung (membrane oxygenator) and back into the bloodstream. This process allows the blood to be oxygenated and carbon dioxide to be removed, effectively mimicking the functions of human lungs and heart.

The growth of the global extracorporeal membrane oxygenation machine (ECMO) market is majorly driven by alarming rise in prevalence of respiratory and cardiac diseases such as heart failure and cardiogenic shock. According to the estimates of the Office of National Statistics, UK, approximately 6.6 million individuals were suffering from either a cardiovascular or respiratory condition. Among these, 3.5 million individuals were reported to have a cardiovascular condition, whereas 3.7 million had a respiratory condition. Moreover, increase in awareness among healthcare providers and advancements in medical training lead have led to a wider adoption of ECMO. Based on the June 2023 assessment by the Extracorporeal Life Support Organization (ELSO) registry, ECMO was used on 151,683 patients in 2020. Among these, 75,735 were adults, 30,743 were children, and 45,205 were neonates. Furthermore, surge in geriatric population notably contributes toward the market growth. . This is attributed to the fact that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for ECMO. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. However, initial investment and maintenance costs of ECMO systems and dearth of skilled personnel to operate the system hamper the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in ECMO technology, including more compact and efficient systems, and increase in government funding and support to set up & develop critical care infrastructure are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The extracorporeal membrane oxygenation machine (ECMO) market is segmented into type, component, application, and region. Depending on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, it is classified into pumps, oxygenator, controllers, and others. On the basis of application, it is segregated into adult, pediatric, and neonates. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the arterio-venous machine segment is expected to dominate the market by 2033.

On the basis of component, oxygenator is anticipated to emerge as a leading segment during the forecast period.

Depending on application, the adult segment is projected to exhibit notable CAGR in the coming years.

Region wise, North America was the major revenue contributor in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global extracorporeal membrane oxygenation machine (ECMO) market include Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, GETINGE AB, Livanova Plc., and Fresnius Medical Care. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Veno-arterial
  • Veno-venous
  • Others

By Components

  • Pumps
  • Oxygenator
  • Controllers
  • Others

By Application

  • Adult
  • Pediatric
  • Neonates

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Medtronic Plc
    • Sorin Group
    • Terumo Corporation
    • MAQUET Holding
    • Nipro Medical Corporation
    • Microport Scientific Corporation
    • Medos Medizintechnik AG
    • GETINGE AB
    • Livanova Plc
    • Fresnius Medical Care

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Veno-arterial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Veno-venous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Components
  • 5.2. Pumps
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Oxygenator
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Controllers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Adult
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Pediatric
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Neonates
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Components
    • 7.2.4. Market Size and Forecast, By Application
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Components
      • 7.2.6.3. Market Size and Forecast, By Application
    • 7.2.7. Canada Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Components
      • 7.2.7.3. Market Size and Forecast, By Application
    • 7.2.8. Mexico Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Components
      • 7.2.8.3. Market Size and Forecast, By Application
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Components
    • 7.3.4. Market Size and Forecast, By Application
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Components
      • 7.3.6.3. Market Size and Forecast, By Application
    • 7.3.7. Germany Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Components
      • 7.3.7.3. Market Size and Forecast, By Application
    • 7.3.8. Italy Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Components
      • 7.3.8.3. Market Size and Forecast, By Application
    • 7.3.9. Spain Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Components
      • 7.3.9.3. Market Size and Forecast, By Application
    • 7.3.10. UK Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Components
      • 7.3.10.3. Market Size and Forecast, By Application
    • 7.3.11. Rest of Europe Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Components
      • 7.3.11.3. Market Size and Forecast, By Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Components
    • 7.4.4. Market Size and Forecast, By Application
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Components
      • 7.4.6.3. Market Size and Forecast, By Application
    • 7.4.7. Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Components
      • 7.4.7.3. Market Size and Forecast, By Application
    • 7.4.8. India Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Components
      • 7.4.8.3. Market Size and Forecast, By Application
    • 7.4.9. South Korea Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Components
      • 7.4.9.3. Market Size and Forecast, By Application
    • 7.4.10. Australia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Components
      • 7.4.10.3. Market Size and Forecast, By Application
    • 7.4.11. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Components
      • 7.4.11.3. Market Size and Forecast, By Application
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Components
    • 7.5.4. Market Size and Forecast, By Application
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Components
      • 7.5.6.3. Market Size and Forecast, By Application
    • 7.5.7. South Africa Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Components
      • 7.5.7.3. Market Size and Forecast, By Application
    • 7.5.8. Saudi Arabia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Components
      • 7.5.8.3. Market Size and Forecast, By Application
    • 7.5.9. Rest of LAMEA Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Components
      • 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic Plc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Sorin Group
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Terumo Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. MAQUET Holding
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Nipro Medical Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Microport Scientific Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Medos Medizintechnik AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. GETINGE AB
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Livanova Plc
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Fresnius Medical Care
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments